Clinical studies of photodynamic therapy for malignant brain tumors: facial nerve palsy after temporal fossa photoillumination

2003 ◽  
Author(s):  
Paul J. Muller ◽  
Brian C. Wilson ◽  
Lothar D. Lilge ◽  
Abhay Varma ◽  
Arjen Bogaards ◽  
...  
Keyword(s):  
Photodynamic Therapy ◽  
Brain Tumors ◽  
Facial Nerve ◽  
Clinical Studies ◽  
Nerve Palsy ◽  
Facial Nerve Palsy ◽  
Temporal Fossa ◽  
Malignant Brain Tumors

scholarly journals Epidemic (rheumatic) facial nerve palsy

2021 ◽  
Vol 25 (11) ◽  
pp. 1239-1239
Author(s):  
E. Sukhova
Keyword(s):  
Herpes Zoster ◽  
Brain Tumors ◽  
Facial Nerve ◽  
Salivary Glands ◽  
Nerve Palsy ◽  
Facial Nerve Palsy ◽  
Starting Point ◽  
The Face ◽  
Slight Rise ◽  
Nerve Disease

Herzog, (Zeitschr fr die gesamte N. und P. 119 Band. 1929), excluding cases of paralysis n. facialis, as a separate symptom in diseases of the middle ear, brain tumors or luese, as well as in cases of infection with herpes zoster, stops at the group of peripheral lesions n. facialis of an epidemic nature. The symptomatology of this form is characterized by a slight swelling of the skin of the face in front of and under the ear, a slight increase in the area of ​​the salivary glands, and a slight rise in temperature. In some cases, a. finds inflammation of the salivary glands of the mouth, especially gl. parotis, which is often the starting point of facial nerve disease. The author gives 4 cases of paralysis n. facialis observed by him in the same autumn month.

TRANSIENT FACIAL NERVE PALSY AFTER SCALP BLOCK FOR AWAKE CRANIOTOMY: A CASE REPORT

2018 ◽  
Vol 4 (5) ◽  
pp. 369-371
Author(s):  
Rajashree U Gandhe . ◽  
Chinmaya P Bhave . ◽  
Avinash S Kakde . ◽  
Neha T Gedam .
Keyword(s):  
Case Report ◽  
Facial Nerve ◽  
Nerve Palsy ◽  
Facial Nerve Palsy ◽  
Awake Craniotomy ◽  
Scalp Block

scholarly journals Facial nerve palsy as the presenting feature of metastatic prostatic cancer in the temporal bone

2020 ◽  
Vol 6 (1) ◽  
pp. 1-5
Author(s):  
Daichi Fujii ◽  
Hikari Shimoda ◽  
Natsumi Uehara ◽  
Takeshi Fujita ◽  
Masanori Teshima ◽  
...  
Keyword(s):  
Facial Nerve ◽  
Temporal Bone ◽  
Prostatic Cancer ◽  
Nerve Palsy ◽  
Facial Nerve Palsy ◽  
Metastatic Prostatic Cancer

scholarly journals HGG-48. ROS1 INHIBITOR ENTRECTINIB USE IN RELAPSE/REFRACTORY INFANTILE GLIOBLASTOMA WITH POSITIVE ROS1 FUSION - A CASE REPORT WITH PROMISING RESPONSE

2020 ◽  
Vol 22 (Supplement_3) ◽  
pp. iii352-iii352
Author(s):  
Dennis Tak-Loi Ku ◽  
Matthew Ming-Kong Shing ◽  
Godfrey Chi-Fung Chan ◽  
Eric Fu ◽  
Ping-Wa Yau ◽  
...  
Keyword(s):  
Targeted Therapy ◽  
Facial Nerve ◽  
Nerve Palsy ◽  
Facial Nerve Palsy ◽  
Tumour Progression ◽  
Molecular Study ◽  
Subtotal Resection ◽  
Residual Tumour ◽  
Molecular Assay ◽  
Debulking Surgery

Abstract INTRODUCTION Infantile glioblastoma is rare with poor prognosis. Recent molecular study for infantile hemispheric high grade glioma found its association with ALK/ROS1/NTRK/MET pathway. This suggested the potential use of targeted therapy for refractory / relapse patients. CASE: A newborn presented with apnea, CT brain showed intracranial haemorrhage. MRI then showed a left parietal tumour with bleeding and mass effect. Craniotomy achieved subtotal resection. Chemotherapy VCR/CPM alternating with CDDP/VP-16 was given for one year. Patient was stable with static residual tumour during chemotherapy. However patient developed status epilepticus two weeks after off treatment. MRI showed significant tumour progression which required 2nd & 3rd debulking surgery. Molecular assay by nanostring panel showed BRAF-KIAA1549 fusion. MEK inhibitor Trametinib was tried for 3 months and stopped as disease progression. Further molecular assay by RNASeq showed presence of ROS1 fusion (ZCCHC8-ROS1) while absent of BRAF fusion. Patient underwent 4th debulking surgery as impending herniation while waiting for the targeted therapy. It was complicated with right hemiplegia and facial nerve palsy postoperatively. Finally, ROS1 inhibitor Entrectinib was started 2 weeks later. It was well tolerated without significant adverse reaction. Patient made dramatic neurological recovery including improved facial nerve palsy, able to walk unaided and self feed. MRI brain 1 and 3 months after Entrectinib showed interval reduction in residual tumour. Patient is currently progression-free for 6 months. CONCLUSION Early molecular study for infantile glioblastoma is useful to guide novel therapy. Molecular result may varies between different panels or change over time, to be interpreted with caution.

scholarly journals A rare case of congenital facial nerve palsy with extreme ocular manifestations

2021 ◽  
Vol 14 (5) ◽  
pp. e242540
Author(s):  
Rahul Kumar Bafna ◽  
Suman Lata ◽  
Anusha Sachan ◽  
Mohamed Ibrahime Asif
Keyword(s):  
Facial Nerve ◽  
Rare Case ◽  
Nerve Palsy ◽  
Facial Nerve Palsy ◽  
Ocular Manifestations

scholarly journals Erratum: Neonatal Cerebellar Hemorrhage and Facial Nerve Palsy: An Unusual Association

2020 ◽  
Vol 10 (03) ◽  
pp. e1-e1
Author(s):  
Caterina Coviello ◽  
Giulia Remaschi ◽  
Sabrina Becciani ◽  
Simona Montano ◽  
Iuri Corsini ◽  
...  
Keyword(s):  
Facial Nerve ◽  
Nerve Palsy ◽  
Facial Nerve Palsy ◽  
Cerebellar Hemorrhage ◽  
Unusual Association
Sign in / Sign up

Export Citation Format

Share Document